Sleep
-
Intranasal saline improves symptoms in children with sleep-disordered breathing
The results of the MIST+ trial support the conclusion that saline is as effective as corticosteroid in managing symptoms of OSDB, said lead author Gillian Nixon, MD.
-
A ‘central’ issue in sleep medicine
An AASM task force recently published guidelines on central sleep apnea management, which includes recommendations on whether adaptive servo-ventilation is a safe option in these patients.
-
AASM issues first guideline for inpatient management of OSA
Sleep specialist Dennis H. Auckley, MD, FCCP, said he hopes the recommendations move the field into the inpatient setting and help to identify those with undiagnosed sleep apnea.
-
Optimal synergy: Coupling smart wearable devices, sensors with AI algorithms
Coupling noninvasive wearable devices with AI-enabled data analytics helps to address two key challenges: health care access and improvement of patient-centric care.
-
Hypoxic burden emerges as a key cardiovascular risk marker in pediatric OSA
Investigator Olga Mediano, PhD, said hypoxic burden may more fully capture the physiological consequences of OSA by integrating the frequency, duration, and depth of oxygen desaturation events.
-
AI applications in pulmonary medicine: From training clinicians to transforming diagnostics and treatment
AI applications in health care are multiplying, and AI-focused research is gaining traction across specialties, including pulmonary, critical care, and sleep medicine.
-
Data show OSA is an independent, modifiable risk factor for cerebral microbleeds
The first prospective, longitudinal study of OSA and cerebral microbleeds (CMBs) found that moderate to severe OSA more than doubles the risk for microbleeds.
-
CMS releases updated guidance for NIPPV in patients with COPD
Understand the new CMS guidance, which comes after more than a decade of strategic advocacy efforts led by CHEST.
-
Study demonstrates strong patient compliance with oral device for OSA
Evidence suggests that an oral device may be an effective alternative for patients who can’t access or tolerate CPAP therapy.
-
Multidisciplinary panel highlights considerations for GLP-1 agonist use in OSA
Chitra Lal, MD, FCCP, discussed the current indications and coverage criteria for use of tirzepatide for treatment of OSA, as well as possible roles for other GLP-1 agonists.
